Adverse event, n (%)

Control group (n = 132)

Itopride group (n = 64)

p-value

At least one adverse event Discontinued due to adverse events Common adverse eventsa

Nausea Diarrhea Abdominal pain Vomiting Chest pain Dyspepsia Dyspnea Flatulence Dizziness

54 (40.9)

37 (26.5)

30 (22.7)

21 (15.9)

6 (4.5)

3 (2.3)

2 (1.5)

2 (1.5)

2 (1.5)

1 (0.8)

1 (0.8)

14 (21.9)

4 (6.3)

6 (9.4)

4 (6.3)

2 (3.1)

0 (0.0)

1 (1.6)

1 (1.6)

1 (1.6)

1 (1.6)

1 (1.6)

0.008

<0.001 0.039 0.094 0.931 0.552 0.552 0.552 0.552 0.817 0.817